Universal Beteiligungs und Servicegesellschaft mbH Buys New Holdings in Inspire Medical Systems, Inc. (NYSE:INSP)

Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in shares of Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 18,535 shares of the company's stock, valued at approximately $2,952,000. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.06% of Inspire Medical Systems as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. SG Americas Securities LLC grew its holdings in Inspire Medical Systems by 14.7% during the first quarter. SG Americas Securities LLC now owns 4,055 shares of the company's stock worth $646,000 after acquiring an additional 521 shares during the period. GAMMA Investing LLC grew its holdings in Inspire Medical Systems by 253.7% during the first quarter. GAMMA Investing LLC now owns 573 shares of the company's stock worth $91,000 after acquiring an additional 411 shares during the period. New York State Teachers Retirement System grew its holdings in Inspire Medical Systems by 132.7% during the first quarter. New York State Teachers Retirement System now owns 21,390 shares of the company's stock worth $3,407,000 after acquiring an additional 12,196 shares during the period. Bessemer Group Inc. grew its holdings in Inspire Medical Systems by 1.7% during the first quarter. Bessemer Group Inc. now owns 7,183 shares of the company's stock worth $1,145,000 after acquiring an additional 123 shares during the period. Finally, Parallel Advisors LLC grew its holdings in Inspire Medical Systems by 356.5% during the first quarter. Parallel Advisors LLC now owns 210 shares of the company's stock worth $33,000 after acquiring an additional 164 shares during the period. Institutional investors and hedge funds own 94.91% of the company's stock.

Inspire Medical Systems Stock Performance

NYSE:INSP traded up $1.61 on Friday, hitting $126.15. The stock had a trading volume of 907,460 shares, compared to its average volume of 558,548. The stock has a market cap of $3.72 billion, a P/E ratio of 58.13, a price-to-earnings-growth ratio of 1.91 and a beta of 1.22. Inspire Medical Systems, Inc. has a 1 year low of $123.25 and a 1 year high of $225.00. The firm's fifty day simple moving average is $131.78 and its two-hundred day simple moving average is $154.92.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last released its quarterly earnings data on Monday, May 5th. The company reported $0.10 earnings per share for the quarter, beating analysts' consensus estimates of ($0.23) by $0.33. The business had revenue of $201.32 million during the quarter, compared to analyst estimates of $194.89 million. Inspire Medical Systems had a net margin of 7.92% and a return on equity of 10.00%. Inspire Medical Systems's revenue was up 22.7% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.34) EPS. Equities research analysts predict that Inspire Medical Systems, Inc. will post 2.16 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on INSP. Wall Street Zen cut Inspire Medical Systems from a "buy" rating to a "hold" rating in a report on Saturday, July 26th. KeyCorp decreased their target price on Inspire Medical Systems from $216.00 to $197.00 and set an "overweight" rating on the stock in a report on Tuesday, July 22nd. Robert W. Baird lifted their target price on Inspire Medical Systems from $230.00 to $236.00 and gave the stock an "outperform" rating in a report on Tuesday, May 6th. Morgan Stanley lowered their price target on Inspire Medical Systems from $200.00 to $182.00 and set an "overweight" rating on the stock in a report on Tuesday, July 15th. Finally, Royal Bank Of Canada lowered their price target on Inspire Medical Systems from $260.00 to $215.00 and set an "outperform" rating on the stock in a report on Tuesday, April 15th. Four research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. According to MarketBeat.com, Inspire Medical Systems presently has a consensus rating of "Moderate Buy" and an average target price of $208.55.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.